Indocid (Indometacin)

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Indocid (Indometacin)

Quick Facts

Property Description
Active ingredient Indometacin (Indomethacin)
Form Capsules (IR/SR), Suppository, Oral Suspension, IV Solution, Topical Gel/Cream
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General purpose Anti-inflammatory, Analgesic (Pain Relief), Antipyretic (Fever Reduction)
Origin Synthetic Compound (Indole-acetic acid derivative)

Indometacin: Classification and Chemical Origin

Indometacin is the established International Nonproprietary Name (INN) for the active chemical substance found in the medicine referenced by trade names such as Indocid. This compound is a synthetic compound, specifically an Indole-acetic acid derivative, a structure that differentiates it chemically from other prominent NSAID groups. The drug is classified within the Pharmacological class of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a category recognized for its therapeutic effects against pain and inflammation. Indometacin, including its many commercial presentations, is generally a Prescription-only medicine (Rx), highlighting its potency and requiring medical oversight for safe use.

What is the Purpose of Indocid (Indometacin)?

The primary purpose of Indometacin is to provide comprehensive relief by directly modulating the body's inflammatory response. It functions as a Non-selective COX inhibitor, meaning its core Mechanism of effect involves potent inhibition of the cyclooxygenase (COX) enzyme system, thereby reducing the biosynthesis of prostaglandins. Prostaglandins are the key chemical messengers that initiate and sustain inflammation. Indometacin exhibits antipyretic and analgesic properties alongside its anti-inflammatory effects. This multi-action profile means the medication helps lessen the sensation of pain, reduces swelling, and aids in normalizing body temperature, making it a foundational treatment option for general inflammatory states.

Available Forms and Compound Structure

Indometacin is consistently a Single active ingredient product, combining the active substance with pharmaceutical excipients appropriate for its intended delivery. The medication is manufactured in several Pharmaceutical preparations to suit different patient needs and Routes of administration. These Dosage form(s) include standard and sustained-release Capsules and Oral suspension for ingestion. Additionally, forms such as Suppositories for rectal administration and Topical gel/cream are manufactured, which allows the anti-inflammatory agent to be delivered systemically or applied locally as required.

Regulatory References

  1. Indomethacin - DailyMed - NIH

What side effects are possible with Indocid (Indometacin)?

Possible Side Effects and Safety Information

The official regulatory profile for Indometacin, an NSAID, details adverse reactions classified by frequency and affected physiological system. Adverse reactions with an incidence greater than 1% (Common) frequently include Central Nervous System effects such as headache and dizziness, alongside common gastrointestinal disturbances like nausea, dyspepsia, and abdominal pain. Effects that occur less frequently are categorized as Uncommon or Rare and span multiple systems.

Documented Serious Adverse Reactions

The label highlights the potential for serious adverse reactions, which include a heightened risk of Cardiovascular (CV) Thrombotic Events, such as myocardial infarction and stroke, which may increase with the duration of use. Similarly, there is a risk of serious Gastrointestinal (GI) Events, including bleeding, ulceration, and perforation, which can occur without warning. Other serious events include severe cutaneous reactions like Stevens-Johnson syndrome (SJS) and hepatotoxicity.

Safety Considerations and Restrictions

Specific safety considerations are noted for certain populations. Older adults are at an increased risk for serious GI and overall adverse events. Patients with advanced renal disease require caution, and use is restricted during the third trimester of pregnancy (from 30 weeks) due to potential fetal risk. Central Nervous System effects are often noted as being more common at the initiation of therapy or during dose increases.

Safety restrictions define that Indometacin is Contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and in individuals with a known history of active GI ulceration or bleeding. This official safety framework provides a clear description of the medicine's documented risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Manifestations and Severity

The official overdose profile for Indometacin, the active component in Indocid, documents expected central nervous system (CNS) effects, including intense headache, dizziness, mental confusion, disorientation, and lethargy. Gastrointestinal (GI) symptoms, such as nausea and vomiting, are also documented manifestations. Severe overdosage carries a risk of life-threatening complications, specifically gastrointestinal ulceration and hemorrhage, alongside severe neurological events like convulsions and coma.

Required Emergency Actions and Management

Regulatory guidance explicitly states that immediate medical attention must be sought if an overdose is suspected or confirmed. Treatment is strictly defined as symptomatic and supportive, as no specific pharmacological antidote is known. Officially documented supportive measures include procedures such as gastric lavage and the administration of activated charcoal (typically 25 or 50 g) if ingestion was recent. Due to the risk of delayed adverse reactions, particularly GI bleeding, the official label requires close medical observation and nursing care for several days following the incident. This monitoring is particularly critical for elderly patients, who are noted to have an increased possibility of severe outcomes.

Therapeutic Uses of Indocid (Indometacin)

What Indocid (Indometacin) Treats: Main Uses and Benefits

Indometacin is primarily used to relieve moderate to severe pain, tenderness, swelling, and stiffness associated with inflammatory conditions. The medication is commonly applied across conditions characterized by periods of heightened symptoms, including Rheumatoid Arthritis, Ankylosing Spondylitis, and Osteoarthritis. It is also applied in acute symptomatic episodes such as Gouty Arthritis flares and bursitis or tendinitis (painful shoulder).

Indometacin is relevant for managing symptom clusters that may become intense or disruptive, offering supportive relief that helps ease the overall symptom burden. The medication is commonly used to help patients cope more steadily with symptom fluctuations in both chronic and sudden-onset inflammatory states. In highly specific cases, it is utilized for targeted symptomatic assistance with certain Indomethacin-responsive headache syndromes and to offer therapeutic support for the clinical management of Patent Ductus Arteriosus in premature infants. By supporting the management of symptoms related to physical discomfort, it assists with maintaining functional stability and contributes to improved comfort during symptomatic periods.


Quick Fact: Relief for Inflammatory Discomfort

Symptom Axis Therapeutic Benefit
Pain, Swelling, Stiffness Supports the patient by easing the overall symptom load.
Acute Flare-ups Applied to manage symptoms that interfere with daily functioning.
Systemic Symptoms Helps with fever and discomfort associated with inflammatory states.

Regulatory References

  1. Indomethacin Rectal: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use

The eligibility profile for Indocid (Indometacin) is strictly determined by regulatory authorities based on patient status, age, and pre-existing conditions. Official labeling defines specific populations who must avoid the medicine.

Absolute Contraindications (Prohibited Use)

Indometacin is officially contraindicated for patients with known hypersensitivity to indometacin or any other NSAID, including those with aspirin-sensitive asthma or other allergic-type reactions. It is also prohibited for pain treatment following coronary artery bypass graft (CABG) surgery and for pregnant women starting at 30 weeks gestation (third trimester). Patients with an active peptic ulcer or a history of recurrent gastrointestinal lesions must not use the medicine.

Age and Condition Restrictions

The safety and efficacy have not been established for most uses of the oral or rectal forms in children younger than 14 years of age. Older adults must use the medicine with greater care. Caution or avoidance is officially advised for patients with advanced renal disease, severe heart failure, or a recent myocardial infarction (MI). Furthermore, use is not recommended for women who are attempting to conceive due to a reversible association with impaired female fertility.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define Indometacin's interaction profile through its effects on pharmacokinetics and pharmacodynamics, establishing specific co-administration restrictions.

Interaction Scope

Indometacin is formally contraindicated for co-administration with Diflunisal and Triamterene. Co-use with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is generally advised against to minimize the risk of serious adverse effects.

Exposure-Modifying Interactions: Indometacin may decrease the elimination of several co-administered medicines, increasing their systemic exposure and the potential for toxicity. This effect is documented for medicines including Lithium, Digoxin, Methotrexate, and Phenytoin.

Pharmacodynamic Interactions: Co-administration with Anticoagulants (such as Warfarin), Antiplatelet agents, and SSRIs may enhance the risk of bleeding due to additive effects on hemostasis. The antihypertensive effect of ACE Inhibitors, ARBs, and Beta-Blockers, as well as the diuretic effect of Thiazide and Loop Diuretics, may be diminished.

Administration Constraints: Indometacin must not be used for 8–12 days after Mifepristone administration. Furthermore, the use of Alcohol and Smoking are cited as documented risk factors that contribute to the risk of serious gastrointestinal bleeding. The heightened risk of renal function deterioration with ACE Inhibitors is noted specifically in the elderly, volume depleted, or renal impaired populations.

Mechanism of Action

Indometacin acts as a nonsteroidal agent whose mechanism of action involves interaction with key enzymatic and signaling pathways that regulate localized and systemic responses. Its primary action is within domains involving enzyme-mediated signaling through the inhibition of Cyclooxygenase (COX) enzymes, specifically both COX-1 and COX-2. This action modifies early molecular steps by blocking the conversion of arachidonic acid into prostaglandins, which are biochemical mediators.

The compound also engages mechanisms that influence processes characterized by heightened pathway activity, independent of COX inhibition. This includes altering the mobilization of leukocytes and the release of other inflammatory mediators. These actions result in the decreased magnitude of certain physiological responses and a reduction in the concentration of specific mediators. Furthermore, Indometacin initiates signaling sequences in the central nervous system. By blocking prostaglandin synthesis in the hypothalamus, it influences the body's temperature control mechanisms, promoting adjustments in the hypothalamic set point and impacting systemic thermal regulation.

Dosage and Administration Information

Official Administration Protocols for Indocid (Indometacin)

Indometacin is officially approved for administration via oral forms (immediate-release capsules, oral suspension, and extended-release capsules), rectal forms (suppository), and a specialized intravenous form used exclusively in the neonatal setting.

The standard adult initial oral regimen for chronic rheumatic conditions typically starts with a dose of 25 mg to 50 mg taken two or three times daily. Dosage adjustments should proceed slowly, utilizing 25 mg or 50 mg increments only at weekly intervals until an effective level is achieved. Regulatory documents restrict the total daily oral intake to a maximum of 200 mg. For acute management, such as a gout flare, the established dose is 50 mg three times daily, followed by rapid dose reduction upon symptom resolution.

To mitigate potential gastrointestinal effects, oral formulations are officially recommended to be taken with food, milk, or an antacid. Administration handling rules mandate that immediate-release capsules must be swallowed whole and must not be crushed, chewed, or opened. A unique scheduling instruction allows up to 100 mg of the total daily dose to be administered at bedtime, often via suppository, to address night pain or morning stiffness.

Specialized rules govern use in specific groups. The IV formulation is strictly administered via a 20 to 30-minute slow infusion using a mg/kg protocol based on the infant’s postnatal age. Official guidance further states that older adults should be managed using the lowest effective dose for the shortest possible duration.

Recent Clinical Evidence

Research evidence / Overview of studies for Indocid (Indometacin)


Research Evidence for Chronic Inflammatory Conditions

Research regarding Indometacin has primarily focused on exploring how symptoms change over time in conditions characterized by fluctuating or episodic manifestations such as Rheumatoid Arthritis, Ankylosing Spondylitis, and Osteoarthritis. Studies have been conducted using Randomized Controlled Trials (RCTs) and long-term comparative trials. Research examined outcomes related to physical discomfort, including changes in pain scores, the duration of morning stiffness, and measurements of joint tenderness and swelling.

Findings from these studies describe patterns observed in the research related to these outcomes linked to inflammatory or irritative states. Data show patterns related to how symptoms evolved during extended observation, consistent with the drug’s regulated indications. What remains uncertain is that the existing evidence base primarily addresses the measurement of episodic or acute changes in symptoms, but it does not characterize any changes in the underlying, progressive course of these chronic conditions.


Research Evidence for Acute Inflammatory Conditions

Indometacin was studied for its evaluation in conditions involving periods of heightened symptoms, such as Acute Gouty Arthritis and Acute Painful Shoulder (Bursitis/Tendinitis). The evidence structure includes clinical trials and regulatory evaluations. These studies monitored outcomes reflecting daily functioning or activity level and outcomes related to physical discomfort, specifically tracking patterns in measured outcomes for localized pain and inflammation.

Research highlights changes in measured outcomes during the study period. For acute gout, for instance, studies focused on episodes where symptoms become more noticeable, tracking patterns of symptom change quickly. The research framework explored short-term symptom patterns, meaning follow-up durations were limited (e.g., 3 to 14 days). Comparative evidence against other agents is limited.


Evidence in Special Populations and Uncertainty

Research has explored the use of Indometacin in specific populations, including its evaluation in preterm infants diagnosed with Patent Ductus Arteriosus (PDA) using a framework of RCTs. Studies observed patterns related to ductal closure rates. However, evidence concerning long-term effects measured in these studies, specifically long-term neurodevelopmental outcomes and patterns in overall mortality in this vulnerable population, remains an area of limited data and is not fully established. For older adults, studies noted that research monitored specific outcomes in this population due to tracked patterns. Data for certain groups remain insufficient.

Key Studies & References

  1. DailyMed - INDOMETHACIN- indomethacin capsule, US National Library of Medicine
  2. Indomethacin (Systemic) (MedlinePlus Drug Information)
  3. Guideline for the management of gout (American College of Rheumatology)

Frequently Asked Questions (FAQ)

Common questions about Indocid (Indometacin) (FAQ)


Q: Is Indocid considered a strong painkiller?

Indocid is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is described in official documents as a potent inhibitor of prostaglandin synthesis. It possesses documented anti-inflammatory, antipyretic (fever-reducing), and analgesic (pain-relieving) properties. Its general use is to provide relief for inflammatory conditions.


Q: Why is Indocid sometimes used for gout attacks?

Indocid is officially found effective in the active stages of acute gouty arthritis and is one of its regulated indications. It is used in these situations because its mechanism of action is described as suppressing the inflammation, relieving the pain, and reducing the swelling and tenderness characteristic of these heightened inflammatory symptoms.


Q: What is the difference between Indocid capsules and suppositories?

The primary difference is the route of administration: capsules are taken orally (by mouth), and suppositories are administered rectally. Official administration protocols note that the suppository form is sometimes used specifically at bedtime to address night pain or morning stiffness.


Q: Does Indocid interact with common over-the-counter pain relievers?

Official documents generally advise that Indocid should not be used at the same time as analgesic doses of aspirin or other NSAIDs (like ibuprofen or naproxen). This restriction is in place due to a potentially increased risk of serious gastrointestinal side effects.


Q: Is it necessary to take Indocid with food?

Official administration instructions recommend that oral formulations be taken with food, milk, or an antacid. This recommendation is described as a strategy to help reduce the potential for gastrointestinal side effects, which are documented risks of the medicine.


Q: Is it true that Indocid can affect the stomach lining?

Yes, official warnings detail a risk of serious Gastrointestinal (GI) events, including bleeding, ulceration, and perforation of the stomach or intestines. This risk is related to the drug's mechanism, which modifies the body's protective systems in the gut.


Q: Can Indocid cause drowsiness or affect driving?

Regulatory documents list central nervous system effects such as dizziness and drowsiness as potential side effects. The product information states that these effects may impair the ability to operate machinery or drive, and regulatory guidelines highlight the need for patient awareness of this risk.


Q: Can taking Indocid long-term cause any permanent problems?

Official warnings state that the risk of serious adverse events, including Cardiovascular Thrombotic Events and severe Gastrointestinal events, may increase with the duration of use. Regulatory documents describe that the medicine should be used for the shortest necessary duration, reflecting the stated risk increase over time.


Q: Does Indocid affect fertility?

Regulatory documents state that use is not recommended for women who are attempting to conceive. This precaution is due to a documented reversible association with impaired female fertility.


Q: What does it mean if my doctor prescribes Indocid for inflammation?

It means the drug is prescribed to reduce the body's inflammatory response. Indocid is a Non-Steroidal Anti-Inflammatory Drug (NSAID) whose mechanism of action is to potently inhibit the cyclooxygenase (COX) enzyme system, thereby reducing the production of chemical messengers that initiate and sustain inflammation.


Q: Does Indocid cause water retention or swelling?

Yes, regulatory documents list metabolic and cardiovascular side effects that include fluid retention (edema) and weight gain. Patients with certain pre-existing conditions are advised to use caution because of this potential effect.


Q: How quickly does Indocid start working for pain?

Official documents indicate that for conditions with heightened symptoms, such as an acute gout attack, a noticeable reduction in pain may be obtained relatively quickly, potentially within 2 to 4 hours. For chronic inflammatory conditions, the full therapeutic effects may take longer to develop.


Q: How long does the effect of one Indocid dose last?

The estimated half-life of indometacin is about 4.5 hours. However, extended-release forms are designed to sustain drug concentrations for a longer duration, with drug release extending over approximately 12 hours.


Q: What is the maximum duration of treatment with Indocid that is generally described?

While a precise maximum duration for all uses is not specified, official prescribing information emphasizes that the medicine should be used at the lowest effective dose for the shortest possible duration. This approach is intended to respect the risk profile associated with the duration of use, as documented in official sources.


Q: Is it possible to develop a tolerance to Indocid?

Some literature has examined the possibility of tolerance. For instance, one small study in healthy volunteers described that tolerance might occur over the course of a week to some central nervous system effects, such as psychomotor impairment, following repeated administration.


Q: What kind of pain is Indocid not recommended for?

Indocid is formally contraindicated (prohibited) for the treatment of peri-operative pain. Specifically, it should not be used in the setting of Coronary Artery Bypass Graft (CABG) surgery.


Q: Can Indocid affect my sleep?

Yes, regulatory documents list central nervous system effects, including drowsiness and insomnia (difficulty sleeping), as potential side effects. These effects may be more common when starting therapy or increasing the dose.

--TUNED

Q: Is Indocid used for muscle spasms?

Indocid is officially indicated for inflammatory conditions like arthritis and gout. While muscle weakness and involuntary muscle movements have been documented as uncommon side effects, its official uses do not include the treatment of muscle spasms.


Q: What are the signs that Indocid is not agreeing with me?

Official information documents specific symptoms of serious adverse events for which patient awareness is highlighted. These include signs of serious gastrointestinal issues (e.g., bloody or black stools, vomiting blood), cardiovascular events (e.g., chest pain, weakness), or severe skin reactions (e.g., rash, blisters, fever).


Q: Is it normal to feel a little dizzy after taking Indocid?

Official regulatory documents classify dizziness as a Common adverse reaction (occurring in 3% to 9% of patients treated). Central Nervous System effects, including dizziness, are noted as being more common at the start of therapy or during dose increases.


Q: What happens if I miss a dose of Indocid?

Official patient guidelines often describe the approach to a missed dose: it is stated that it can be taken as soon as possible, unless it is almost time for the next scheduled dose. If that is the case, the missed dose should be skipped, and patients are explicitly advised not to take a double dose to compensate.


Q: What should I do if I suspect an interaction between Indocid and another medicine?

Official patient counseling documents the instruction that if any adverse signs or symptoms occur or if interactions are suspected, the patient should discontinue the medication immediately and seek medical advice.


Q: Can Indocid affect mood or cause anxiety?

Official documents list various uncommon or rare Central Nervous System and Psychiatric side effects, including anxiety, nervousness, and depression. These effects are generally classified as less common.


Q: What is the main purpose of the research studies on Indocid?

The research primarily aims to demonstrate the drug's effectiveness and safety profile in providing symptomatic treatment for its regulated indications. Studies focus on monitoring changes in subjective outcomes like pain, stiffness, and swelling.


Q: Is there a link between Indocid and liver problems?

Official documents include warnings about the potential for serious Hepatotoxicity (liver injury). This risk can range from liver enzyme abnormalities to rare, severe cases of liver failure, and patients are advised to be alert for symptoms like jaundice.


Q: Is there a preferred time of day to take Indocid?

While a general preferred time is not stated, official administration protocols allow a portion of the total daily dose, up to 100 mg, to be administered at bedtime. This specific scheduling is typically used to address night pain or morning stiffness.


Q: Can Indocid be split or crushed?

Official administration rules mandate that immediate-release capsules must be swallowed whole and must not be crushed, chewed, or opened.

How should Indocid (Indometacin) be stored and disposed of?

Official Storage and Disposal Instructions

Indometacin must be stored according to regulatory labeling to ensure product quality and public safety. Capsules should be kept at Controlled Room Temperature, generally between 20 C and 25 C (68 F to 77 F). The container must be closed and stored in a dry place and protected from moisture.

The medication must be stored away from heat and direct light, and you must prevent freezing. For safety, always keep Indometacin products out of the reach of children.

Disposal

Discard unused or expired Indometacin by following instructions from a healthcare professional or a designated medicine take-back program. Do not flush the medicine down the toilet or pour it into a drain unless explicitly instructed to do so by a regulatory authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indocid (Indometacin) found in:

A-Z Index: